Subsequently, we developed a novel AFP-based model, named ASAP (age, sex, (log)AFP, (log)PIVKA-II), which performed equally well as the GALAD score in detecting low AFP early-stage HCC and showed even greater potential for very early HCC detection, up to 13 months before diagnosis. Here, AFP is linked to hepatocellular carcinoma.